← All peptides

DSIP (Delta Sleep-Inducing Peptide)

Research Use Only
peptideSubcutaneous injectionIntranasal

A brain peptide that helps you get more deep sleep (the restorative delta-wave kind). It normalizes disrupted sleep patterns and reduces stress, and unlike many sleep aids, you won't feel groggy the next morning.

What to Expect

1

Week 1–2

Improved sleep onset and increased delta wave sleep within the first few nights. Reduced time to fall asleep. More restorative, deeper sleep cycles.

2

Week 3–6

Normalized sleep architecture. Reduced stress response and cortisol levels. Improved next-day energy and cognitive performance from better sleep quality.

3

Week 8+

Sustained sleep improvements. Stress resilience improved via HPA axis normalization. Some users report reduced chronic pain perception.

Common Side Effects

Morning grogginess (dose-dependent)HeadacheMild hypotensionVivid dreams
Tolerance: Mild after 4-6 weeks — cycling helps maintain efficacy
Cycling: 3-4 weeks on, 2 weeks off. Use as needed rather than continuously for best results.

Scientific Overview

Delta Sleep-Inducing Peptide is a nonapeptide (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) originally isolated from cerebral venous blood during electrically induced sleep. DSIP modulates sleep architecture by increasing delta wave (Stage III/IV) activity without suppressing REM sleep. It acts through modulation of serotonergic and GABAergic systems and has demonstrated stress-protective effects via normalization of the hypothalamic-pituitary-adrenal axis. DSIP also exhibits opiate antagonist properties and has been investigated for withdrawal symptom management.

Dosing

100-200 mcg subq or nasal spray about 30 minutes before bed. Use 5 days on, 2 days off.

Practical Guide

Reconstitution

Mix 5mg vial with 2mL BAC water. Typical dose is 100-300mcg.

Storage

Refrigerate after reconstitution. Use within 21 days. Fragile peptide — handle gently.

Injection Sites

Lower abdomenOuter thigh

Subcutaneous with insulin syringe. Very small injection volume. Some administer intranasally.

Timing

Inject 30-60 minutes before desired sleep time. Do not use during daytime.

Food

No food interactions. Avoid alcohol, which disrupts sleep architecture.

Benefit Profile

😴 Sleep
10/10
😌 Mood & Anxiety
5/10
Longevity
3/10

Medical Considerations

Medical oversight recommendedNot safe during pregnancy

Contraindications

  • Pregnancy/nursing
  • Severe hypotension
  • Respiratory depression conditions

Drug Interactions

Benzodiazepines and sleep aids (additive sedation)Opioids (enhanced respiratory depression risk)Alcohol (additive CNS depression)Antihypertensives (additive hypotension)

Recommended Monitoring

  • Blood pressure monitoring
  • Sleep quality assessment

This information is for educational purposes only. Always consult a qualified healthcare provider before starting any peptide protocol.

Pricing

VendorVariantPrice
Limitless Biotech5mg$38.99
Code: PSTACK10Buy
Skye Peptides5mg$34.99
Amino Asylum
Reported federal raid in 2025
5mg$29.99BEST
Peptide Sciences
Announced voluntary shutdown
5mg$45.00

Published Research

20 studies indexed(1981–2026)6 clinical trials9 reviews

Delta sleep-inducing peptide alters bispectral index, the electroencephalogram and heart rate variability when used as an adjunct to isoflurane anaesthesia.

Pomfrett CJ, Dolling S, et al.·Eur J Anaesthesiol·2009
Clinical Trial

Delta-sleep-inducing peptide does not affect CRH and meal-induced ACTH and cortisol secretion.

Späth-Schwalbe E, Schäfer A, et al.·Psychoneuroendocrinology·1995
Clinical Trial

Effects of delta sleep-inducing peptide on sleep of chronic insomniac patients. A double-blind study.

Bes F, Hofman W, et al.·Neuropsychobiology·1992
Clinical Trial

Study of delta sleep-inducing peptide efficacy in improving sleep on short-term administration to chronic insomniacs.

Monti JM, Debellis J, et al.·Int J Clin Pharmacol Res·1987
Clinical Trial

DSIP in insomnia.

Schneider-Helmert D·Eur Neurol·1984
Clinical Trial

The influence of synthetic DSIP (delta-sleep-inducing-peptide) on disturbed human sleep.

Schneider-Helmert D, Schoenenberger GA·Experientia·1981
Clinical Trial

Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions.

Rahman OF, Lee SJ, Seeds WA·J Am Acad Orthop Surg Glob Res Rev·2026
Review

Delta sleep-inducing peptide and glucocorticoid-induced leucine zipper: potential links between circadian mechanisms and obesity?

Gimble JM, Ptitsyn AA, et al.·Obes Rev·2009
Review

[Endogenous anticonvulsants: neuropeptide Y and delta sleep inducing peptide].

Stanojlović O, Hrncić D, Radosavljević T·Med Pregl·2008
Review

Delta sleep-inducing peptide (DSIP): a still unresolved riddle.

Kovalzon VM, Strekalova TV·J Neurochem·2006
Review
Showing 10 of 20 studies. Search PubMed for the complete list.